U.S. Gene Therapy Market Outlook: Trends, Innovations, and Growth Forecast 2024-2030
The U.S. gene therapy market size is anticipated to reach USD 10.40 billion by 2030, expanding at a CAGR of 19.21% during the forecast period, according to a new report by Grand View Research, Inc. The market growth can be attributed to various factors such as the expanding area of advanced therapies along with gene delivery technologies and increased competition among key players focused on the commercialization of their therapies. Similar to many other industries, the COVID-19 pandemic has had an impact on the U.S. market for gene therapy. While the market is expected to grow significantly in the coming years, the pandemic has caused delays in clinical trials and disruptions in the supply chain. The pandemic also highlighted the importance of gene therapy in treating and preventing diseases, which could lead to increased funding and investment in the field. Overall, while the pandemic has caused some challenges for the U.S. gene therapy industry, there i...